you are here: HomeNewsCovishield
covishield
Jump to
193 Results Found
  • COVID-19 vaccine update | Karnataka to restart vaccination for ages 18-44, will get 2 lakh Covishield doses today May 21, 2021 11:07 AM IST

    COVID-19 vaccine update | Karnataka to restart vaccination for ages 18-44, will get 2 lakh Covishield doses today

    The state also emphasised that it will “prioritise” frontline workers and priority groups such as cab drivers and bank officials.

  • How India’s vaccination drive could play out with the available shots May 19, 2021 05:37 PM IST

    How India’s vaccination drive could play out with the available shots

    By August, suggest some experts, the situation will ease. July is the crucial month when indigenous production of vaccines will go up, as will imports

  • Exclusive | Government has not restricted vaccine makers and will not ban commercial exports, say officials May 19, 2021 02:26 PM IST

    Exclusive | Government has not restricted vaccine makers and will not ban commercial exports, say officials

    As the debate on allowing vaccine exports in the face of local shortage gains momentum, senior officials across key ministries say companies are free to honour their contractual obligations and sell abroad if they have enough doses

  • COVID-19 vaccine | Never exported vaccines at the cost of the people of India, says Serum Institute's Adar Poonawalla May 18, 2021 07:47 PM IST

    COVID-19 vaccine | Never exported vaccines at the cost of the people of India, says Serum Institute's Adar Poonawalla

    However, the company hopes to begin deliveries of vaccine to COVAX and other countries by end of 2021.

  • When to get the second dose of COVID-19 vaccine? Read on to find out May 18, 2021 04:32 PM IST

    When to get the second dose of COVID-19 vaccine? Read on to find out

    The Central government, last week, increased the gap between Covishield vaccine doses to 12-16 weeks.

  • Dr Gagandeep Kang on Covishield 2nd dose & why plasma therapy isn’t good May 17, 2021 05:22 PM IST

    Dr Gagandeep Kang on Covishield 2nd dose & why plasma therapy isn’t good

    One of India's top vaccine experts Dr Gagandeep Kang spoke to Moneycontrol's Chandra R Srikanth on the Government's vaccination roadmap, why there should be central procurement, if it is advisable to take the second dose of Covishield after 12 weeks and why plasma therapy should be dropped. She also spoke about when the second wave of Coronavirus began to taper in India.

  • Bleeding and clotting events following COVID-19 vaccination 'minuscule', says govt panel May 17, 2021 03:25 PM IST

    Bleeding and clotting events following COVID-19 vaccination 'minuscule', says govt panel

    The National AEFI Committee found that till April 3, 26 incidents of potential thromboembolic cases (blood clotting) following the administration of the Covishield vaccine were reported in India, with a reporting rate of 0.61 cases/ million doses.

  • Already booked online appointments for 2nd Covishield dose to remain valid: Govt May 16, 2021 10:51 PM IST

    Already booked online appointments for 2nd Covishield dose to remain valid: Govt

    The Centre had on May 13 extended the gap between the first and second doses of Covishield vaccine to 12-16 weeks based on the recommendations by the COVID Working Group chaired by N K Arora.

  • Govt reconfigures CoWIN to reflect change in Covishield vaccine dose interval of 12-16 weeks May 16, 2021 06:57 PM IST

    Govt reconfigures CoWIN to reflect change in Covishield vaccine dose interval of 12-16 weeks

    The two jabs of the Serum Institute of India (SII)-manufactured Covishield vaccine were earlier administered at a gap of six-to-eight weeks.

  • Has Covishield dose interval extended due to vaccine crunch? 'Saddened' by such allegations, says Dr VK Paul May 15, 2021 05:19 PM IST

    Has Covishield dose interval extended due to vaccine crunch? 'Saddened' by such allegations, says Dr VK Paul

    Dr VK Paul's response to the controversy comes two days after the Centre, based on an expert panel's recommendation, increased the gap between two doses of Covishield vaccine from 6-8 weeks to 12-16 weeks.

  • Centre to supply over 19 million doses of COVID-19 vaccines to states, UTs for free May 14, 2021 01:23 PM IST

    Centre to supply over 19 million doses of COVID-19 vaccines to states, UTs for free

    During 16-31 May, 191.99 lakh doses of Covishield and Covaxin will be supplied to the States and UTs, free of cost.

  • Herd Immunity Part 2: Is the race a sprint or a marathon? May 14, 2021 12:10 PM IST

    Herd Immunity Part 2: Is the race a sprint or a marathon?

    In terms of Fauci’s estimated threshold (70 percent) for herd immunity, India might reach that goal by mid-November.

  • India should work with other countries to boost COVID-19 vaccine availability: Dr Anthony Fauci May 14, 2021 10:34 AM IST

    India should work with other countries to boost COVID-19 vaccine availability: Dr Anthony Fauci

    On India's decision to extend the gap between two Covishield doses, Dr Anthony Fauci said that it is a "reasonable approach".

  • Coronavirus India News Highlights: COVID pandemic to be 'far more deadly' this year, WHO warns May 14, 2021 07:53 AM IST

    Coronavirus India News Highlights: COVID pandemic to be 'far more deadly' this year, WHO warns

    Coronavirus India News Highlights: The cumulative number of COVID-19 vaccine doses administered inched closer to 18 crore, the Union Health Ministry said.

  • As vaccines become scarce, states adopt different strategies to secure supplies May 13, 2021 06:22 PM IST

    As vaccines become scarce, states adopt different strategies to secure supplies

    While some municipalities are, or will issue tenders to procure vaccines, others are directly talking to manufacturers. The smaller provinces seem to be depending on distribution by the central government.

  • More than 2 billion doses of COVID-19 vaccines to become available: Govt May 13, 2021 05:55 PM IST

    More than 2 billion doses of COVID-19 vaccines to become available: Govt

    Around 750 million doses of Covishield and 550 million doses of Covaxin would be available in the period between August and December, said Niti Aayog member Dr VK Paul.

  • COVID-19 Vaccine | Gap between two Covishield doses extended to 12-16 weeks: Union Health Ministry May 13, 2021 04:44 PM IST

    COVID-19 Vaccine | Gap between two Covishield doses extended to 12-16 weeks: Union Health Ministry

    The suggestion to increase the gap between two Covishield doses was made by the National Technical Advisory Group on Immunisation (NTAGI).

  • NTAGI suggests increasing dosage interval of Covishield to 12-16 weeks May 13, 2021 12:09 PM IST

    NTAGI suggests increasing dosage interval of Covishield to 12-16 weeks

    Currently, India is facing an acute nationwide shortage of the Covishield vaccine and Serum Institute is struggling to keep up with demand.

  • Maharashtra COVID-19 vaccination for 18-44 age group to resume after SII sends 1.5 crore Covishield doses May 12, 2021 08:15 PM IST

    Maharashtra COVID-19 vaccination for 18-44 age group to resume after SII sends 1.5 crore Covishield doses

    Maharashtra Health Minister Rajesh Tope has said COVID-19 vaccination for the 18-44 age group has been suspended temporarily due to vaccine shortage.

  • Where to get the cheapest jab for COVID-19 across metro cities: Check here May 11, 2021 04:52 PM IST

    Where to get the cheapest jab for COVID-19 across metro cities: Check here

    The cheapest option among all metro cities to get the jab at a private setup is at HN Reliance Hospital where you can get a dose of Covishield for Rs 700.

  • Kerala receives 3.5 lakh doses of Covishield May 10, 2021 01:15 PM IST

    Kerala receives 3.5 lakh doses of Covishield

    An Indigo regular flight carrying the Covishield vaccine landed at Cochin International Airport at 11.50 AM, a CIAL spokesman said.

  • COVID-19: Madras HC calls for revival of government-owned vaccine institutes May 09, 2021 03:44 PM IST

    COVID-19: Madras HC calls for revival of government-owned vaccine institutes

    Covaxin is developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology

  • COVID-19 | Second or third generation versions of Indian variant may be more dangerous, says expert May 06, 2021 05:46 PM IST

    COVID-19 | Second or third generation versions of Indian variant may be more dangerous, says expert

    The new observations which Prof Haseltine pointed out have more chances to be correct as the new variants of COVID-19 may be currently racing through India’s tightly-packed population of 1.4 billion people.

  • COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered May 06, 2021 11:27 AM IST

    COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered

    What does the US decision to support an initiative at WTO for temporary waiver of patent protection for COVID-19 vaccines mean for India? Below is a primer.

  • Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts May 05, 2021 12:43 PM IST

    Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts

    Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.

Sections